Data / Form D filings / SonoThera, Inc.
SonoThera, Inc.: Form D filings
SonoThera, Inc., a biotechnology company in South San Francisco, CA, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on June 30, 2026, reports $125.5 million sold of a $125.5 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 201 HASKINS WAY, 5TH FLOOR, South San Francisco, CA, 94080
- Phone
- (510) 414-2997
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1945154
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | New notice | $125,450,218 | $125,450,218 | 22 | Jun 8, 2026 | sec.gov | |
| Dec 29, 2022 | New notice | $60,750,000 | $30,375,000 | $30,375,000 | 12 | Apr 29, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth Greenberg | Executive Officer, Director | |
| Michael Davidson | Executive Officer, Director | |
| Steven Gillis | Director | |
| Brian Halak | Director | |
| Rajul Jain | Director | |
| Rakhshita Dhar | Director | |
| Steven Feinstein | Executive Officer | |
| Carolyne Zimmerman | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 29, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SonoThera, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.